Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil is less effective on eyebrows and eyelashes than scalp hair because these areas have lower enzyme activity needed to activate the drug.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Health warnings and public health actions led to a significant drop in flutamide prescriptions for women, but off-label use still continues.

Bicalutamide may help treat female pattern hair loss.

New medications are improving depression treatment, emphasizing accurate diagnosis and chronic care.

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

The document concludes that stem cells and their environments are crucial for skin and hair health and have potential for medical treatments.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Hair loss can be managed with treatments like minoxidil, finasteride, and others, but there are still gaps in effectiveness and off-label usage is increasing.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

H-1 antihistamines may help with various skin conditions, but more research is needed to confirm their effectiveness.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

Finasteride helps treat frontal fibrosing alopecia, improving or stabilizing the condition in many patients.

Methotrexate is a key, cost-effective drug for skin conditions, but requires careful monitoring for side effects.

The conclusion is that effectively treating hair disorders is difficult due to the complex factors affecting hair growth and more research is needed to improve treatments.

Dutasteride is more effective than finasteride for hair growth, and sublingual apomorphine quickly improves Parkinson's symptoms.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Minoxidil and spironolactone can improve hair growth, but responses vary and side effects are common.

Ketoconazole cream is effective for skin conditions like seborrheic dermatitis and may help with hair loss and other skin issues, with generally mild side effects.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

Spironolactone is effective and safe for treating acne.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

The document concludes that women should not use 5-alpha-reductase inhibitors due to the risk of birth defects and limited effectiveness.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

The document concludes that proper treatment and management of plaque psoriasis in adolescents can improve their quality of life.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.